Inoperable chronic thromboembolic pulmonary hypertension: Evolution of prognosis over 10 years of new emerging therapies

22 August 2024

Diederik P. Staal, Paul M. Hendriks, Mitch C. J. van Thor, Liza D. van de Groep, Leon M. van den Toorn, Berend-Jan M. Mulder, Prewesh P. Chandoesing, Robert M. Kauling, Sanne Boerman, Annemien E. van den Bosch, Johannes J. Mager, Karin A. Boomars, Martijn C. Post

https://doi.org/10.1002/pul2.12419

Abstract

Therapies for inoperable chronic thromboembolic pulmonary hypertension (CTEPH) include balloon pulmonary angioplasty (BPA) and PH-specific medical therapy. This study compares survival and its predictors before and after the introduction of BPA. BPA was independently associated with survival; however, there was no difference in overall survival between the two cohorts.

Read the full research letter

Share:

Other materials on this topic

Additional comments are available to members. Login or register to become a member today
RegisterorLogin to view

More from Pulmonary Circulation

Show more details

A collection of up-to-date abstracts from our premier, international, peer-reviewed, medical research journal dedicated exclusively to pulmonary circulation and pulmonary vascular disease. 

Better efficacy of sequential combination with balloon pulmonary angioplasty after long-term riociguat for patients with inoperable chronic thromboembolic pulmonary hypertension
Pulmonary perfusion in long-term survivors of COVID-19-related severe acute respiratory distress syndrome treated by extracorporeal membrane oxygenation
Novel evaluation of pulmonary hypertension associated with chronic lung disease using perfusion SPECT/CT: A pilot study
Editorial on “Characteristics and risk profiles of patients with pulmonary arterial or chronic thromboembolic pulmonary hypertension living permanently at >2500 m of high altitude in Ecuador”
Impact of selexipag maintenance dose on persistence, adherence, and hospitalization in US patients with pulmonary arterial hypertension
Carnitine consumption and effect of oral supplementation in human pulmonary arterial hypertension: A pilot study
Pretransplant NT-proBNP levels are associated with mortality among lung transplant recipients
Air travel in patients suffering from pulmonary hypertension—A prospective, multicentre study
Immature reticulocyte fraction: A novel biomarker of hemodynamic severity in pulmonary arterial hypertension
Clinical characteristics and anticoagulation patterns of patients with acute pulmonary thromboembolism and hemoptysis
Editorial on “A systematic review of the impact of pulmonary thromboendarterectomy on health related quality of life”
Selexipag in patients with pulmonary arterial hypertension associated with connective tissue disease (PAH-CTD): Real-world experience from EXPOSURE
Early detection of pulmonary arterial hypertension through [18F] positron emission tomography imaging with a vascular endothelial receptor small molecule
Integrated approach of network pharmacology, molecular docking, and clinical observations in evaluating the efficacy and safety of Bufei Huoxue capsules for pulmonary hypertension associated with chronic obstructive pulmonary disease
We are all in this together: Understanding organ crosstalk in the pathogenesis of acute respiratory distress syndrome